Screener
BioMarin Pharmaceuticals BMRN Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| INCOME BEFORE INCOME TAXES | 61,384 | 297,868 | 202,587 | 535,957 |
| Provision for income taxes | 16,622 | 57,336 | 52,298 | 109,739 |
| NET INCOME | $44,762 | $240,532 | $150,289 | $426,218 |
| EARNINGS PER SHARE, BASIC | $0.23 | $1.25 | $0.78 | $2.23 |
| EARNINGS PER SHARE, DILUTED | $0.23 | $1.23 | $0.77 | $2.19 |
| Weighted average common shares outstanding, basic | 193,423 | 191,907 | 192,959 | 191,440 |
| Weighted average common shares outstanding, diluted | 194,467 | 197,091 | 194,147 | 196,643 |
| COMPREHENSIVE INCOME | $40,216 | $176,816 | $154,979 | $320,000 |
Item 1. Financial Statements
FAQ
- What is BioMarin Pharmaceuticals's shares (diluted)?
- BioMarin Pharmaceuticals (BMRN) reported shares (diluted) of 194.5M in Q2 2026.
- How has BioMarin Pharmaceuticals's shares (diluted) changed year-over-year?
- BioMarin Pharmaceuticals's shares (diluted) decreased by 1.3% year-over-year, from 197.1M to 194.5M.
- What is the long-term trend for BioMarin Pharmaceuticals's shares (diluted)?
- Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's shares (diluted) has grown at a 1.6% compound annual growth rate (CAGR), from 735.9M to 783M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about BioMarin Pharmaceuticals's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude